retatrutide phase 3 triumph A summary slide of the TRIUMPH-1 data presented today by Dr. Ania Jastreboff at #ADA2026 🚨 TRIUMPH-1: Obesity Trial with Retatrutide 🚨 Retatrutide 💉, a once-weekly triple hormone receptor Retatrutide Phase 3: TRIUMPH Program

(NIDDK) Do GLP-1 medications replace diet and exercise

They should be able to interpret body composition data, metabolic breath analysis, and blood biomarkers

This extended presence allows convenient once-weekly dosing but also means effectsboth therapeutic and adversepersist for several weeks after discontinuation

The Topical Cream Advantage: Precision Delivery Topical administration represents the ideal delivery method for AOD-9604, providing targeted action exactly where its needed while minimizing systemic exposure

Safety Considerations and Who Should Monitor More Closely Women with polycystic ovary syndrome (PCOS), endometriosis, or dysmenorrhea already experience dysregulated hormonal cycles and heightened GI sensitivity